BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25604439)

  • 1. Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice.
    Recio C; Oguiza A; Mallavia B; Lazaro I; Ortiz-Muñoz G; Lopez-Franco O; Egido J; Gomez-Guerrero C
    Basic Res Cardiol; 2015 Mar; 110(2):8. PubMed ID: 25604439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.
    Ortiz-Muñoz G; Martin-Ventura JL; Hernandez-Vargas P; Mallavia B; Lopez-Parra V; Lopez-Franco O; Muñoz-Garcia B; Fernandez-Vizarra P; Ortega L; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):525-31. PubMed ID: 19164812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.
    Recio C; Oguiza A; Lazaro I; Mallavia B; Egido J; Gomez-Guerrero C
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1953-60. PubMed ID: 25012131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
    Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
    Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.
    Tamiya T; Kashiwagi I; Takahashi R; Yasukawa H; Yoshimura A
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):980-5. PubMed ID: 21508344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional conservation of suppressors of cytokine signaling proteins between teleosts and mammals: Atlantic salmon SOCS1 binds to JAK/STAT family members and suppresses type I and II IFN signaling.
    Skjesol A; Liebe T; Iliev DB; Thomassen EI; Tollersrud LG; Sobhkhez M; Lindenskov Joensen L; Secombes CJ; Jørgensen JB
    Dev Comp Immunol; 2014 Jul; 45(1):177-89. PubMed ID: 24582990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressors of cytokine signaling abrogate diabetic nephropathy.
    Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
    J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese encephalitis virus infection modulates the expression of suppressors of cytokine signaling (SOCS) in macrophages: implications for the hosts' innate immune response.
    Kundu K; Dutta K; Nazmi A; Basu A
    Cell Immunol; 2013; 285(1-2):100-10. PubMed ID: 24140964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knocking off the suppressors of cytokine signaling (SOCS): their roles in mammalian pregnancy.
    Fitzgerald JS; Toth B; Jeschke U; Schleussner E; Markert UR
    J Reprod Immunol; 2009 Dec; 83(1-2):117-23. PubMed ID: 19853926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
    Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
    Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
    Sikorski K; Czerwoniec A; Bujnicki JM; Wesoly J; Bluyssen HA
    Cytokine Growth Factor Rev; 2011 Aug; 22(4):211-9. PubMed ID: 21752694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J; López-Franco O; Blanco-Colio LM; Muñoz-García B; Ramos-Mozo P; Ortega L; Egido J; Martín-Ventura JL
    Cardiovasc Res; 2010 May; 86(2):330-7. PubMed ID: 20154064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-155 Promotes Atherosclerosis Inflammation via Targeting SOCS1.
    Yang Y; Yang L; Liang X; Zhu G
    Cell Physiol Biochem; 2015; 36(4):1371-81. PubMed ID: 26159489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17β-estradiol suppresses the macrophage foam cell formation associated with SOCS3.
    Liang X; He M; Chen T; Wu Y; Tian Y; Zhao Y; Shen Y; Liu Y; Yuan Z
    Horm Metab Res; 2013 Jun; 45(6):423-9. PubMed ID: 23430591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor of cytokine signaling 3 inhibits head kidney macrophage activation and cytokine expression in Scophthalmus maximus.
    Zhang M; Xiao ZZ; Sun L
    Dev Comp Immunol; 2011 Feb; 35(2):174-81. PubMed ID: 20869394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant Effects of PS5, a Peptidomimetic of Suppressor of Cytokine Signaling 1, in Experimental Atherosclerosis.
    La Manna S; Lopez-Sanz L; Bernal S; Jimenez-Castilla L; Prieto I; Morelli G; Gomez-Guerrero C; Marasco D
    Antioxidants (Basel); 2020 Aug; 9(8):. PubMed ID: 32824091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.
    Hernández-Vargas P; López-Franco O; Sanjuán G; Rupérez M; Ortiz-Muñoz G; Suzuki Y; Aguado-Roncero P; Pérez-Tejerizo G; Blanco J; Egido J; Ruiz-Ortega M; Gómez-Guerrero C
    J Am Soc Nephrol; 2005 Jun; 16(6):1673-83. PubMed ID: 15829701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressors of Cytokine Signaling (SOCS)1 and SOCS3 Proteins Are Mediators of Interleukin-10 Modulation of Inflammatory Responses Induced by
    Duncan SA; Sahu R; Dixit S; Singh SR; Dennis VA
    Mediators Inflamm; 2020; 2020():7461742. PubMed ID: 32684836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.